Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Basc4 (AA 100-211) antibody

The Rabbit Polyclonal anti-Basc4 antibody is suitable to detect Basc4 in samples from Human. It has been validated for ELISA, IF (cc), IF (p), IHC (fro) and IHC (p).
Catalog No. ABIN759956
$384.62
Plus shipping costs $50.00
100 μL
Shipping to: United States
Delivery in 4 to 7 Business Days

Quick Overview for Basc4 (AA 100-211) antibody (ABIN759956)

Target

Basc4

Reactivity

Human

Host

Rabbit

Clonality

Polyclonal

Application

ELISA, Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p)), Immunohistochemistry (Frozen Sections) (IHC (fro)), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
  • Binding Specificity

    AA 100-211

    Cross-Reactivity

    Human

    Purification

    Purified by Protein A.

    Immunogen

    KLH conjugated synthetic peptide derived from human BASC4

    Isotype

    IgG
  • Application Notes

    ELISA 1:500-1000
    IHC-P 1:200-400
    IHC-F 1:100-500
    IF(IHC-P) 1:50-200
    IF(IHC-F) 1:50-200
    IF(ICC) 1:50-200

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    1 μg/μL

    Buffer

    0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.

    Preservative

    ProClin

    Precaution of Use

    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

    Storage

    4 °C,-20 °C

    Storage Comment

    Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.

    Expiry Date

    12 months
  • Target

    Basc4

    Background

    Synonyms: BCAS4, BCAS4/BCAS3 fusion, BCAS4_HUMAN, Breast carcinoma amplied sequence 4, Breast carcinoma amplied sequence 4/3 fusion protein, Breast carcinoma-amplied sequence 4, CNOL.

    Background: Brain, thymus, spleen, kidney and placenta. Overexpressed in most breast cancer cell lines.

    Gene ID

    55653
You are here:
Chat with us!